Related Experiment Video
Updated: Jun 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles
Lynsey Corless1, Colin M Crump, Stephen D C Griffin
1Institute of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, West Yorkshire, UK.
Insights
Hepatitis C virus (HCV) release depends on the endosomal sorting complex required for transport (ESCRT) pathway. Late ESCRT-III and Vps4 components are crucial for infectious HCV particle production and release from cells.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) assembly and release mechanisms are not fully understood.
- Enveloped viruses like HIV-1 use the host's endosomal sorting complex required for transport (ESCRT) machinery for particle formation and release.
- The role of the ESCRT pathway in HCV egress remains to be elucidated.
Purpose of the Study:
- To investigate whether the ESCRT pathway is involved in the release of infectious Hepatitis C virus (HCV) particles.
- To determine which specific components of the ESCRT pathway are essential for HCV egress.
Main Methods:
- Established a conditional virus-like particle (VLP) assembly system using trans-complementation of an envelope-deleted JFH-1 genome.
- Utilized dominant-negative mutants of ESCRT-III components and Vps4 to inhibit ESCRT pathway function.
- Assessed the impact of ESCRT inhibition on infectious particle production, virus genome replication, and intracellular infectious particle accumulation using focus-forming assays.
Main Results:
- Inhibition of late ESCRT-III components or Vps4 significantly reduced the production of infectious HCV particles.
- Dominant-negative ESCRT-I or Alix did not affect HCV particle release.
- ESCRT inhibition did not impact HCV genome replication or the accumulation of intracellular infectious particles, indicating a specific role in release.
Conclusions:
- HCV requires late components of the ESCRT pathway, specifically ESCRT-III and Vps4, for the efficient release of infectious virus particles.
- The ESCRT pathway plays a critical role in the egress of Hepatitis C virus from infected host cells.
Abstract:
The mechanisms by which infectious hepatitis C virus (HCV) particles are assembled and released from infected cells remain poorly characterized. In this regard, many other enveloped viruses, notably human immunodeficiency virus type 1, have been shown to utilize the host vacuolar protein sorting machinery (also known as the endosomal sorting complex required for transport; ESCRT) to traffic through the cell and effect the membrane rearrangements required for the formation of enveloped particles. We postulated that this might also apply to HCV. To test this hypothesis, we established a method of conditional virus-like particle assembly involving trans-complementation of an envelope-deleted JFH-1 genome using plasmid transfection. This system reliably produced virus particles that were infectious and could be enumerated easily by focus-forming assay in Huh7 cells. Following co-transfection with plasmids expressing various dominant-negative forms of either components of the ESCRT-III complex or Vps4 (the AAA ATPase that recycles the ESCRT complexes), a reduction in particle production was seen. No significant effect was observed after co-transfection of dominant-negative ESCRT-I or Alix, an ESCRT associated protein. Dominant-negative Vps4 or ESCRT-III components had no effect on either virus genome replication or the accumulation of intracellular infectious particles. These data were confirmed using cell culture infectious HCV and we conclude that HCV requires late components of the ESCRT pathway for release of infectious virus particles.
Related Concept Videos
Hepatitis
Intralumenal Vesicles and Multivesicular Bodies
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles

